First Commercial Delivery to Cirtec Medical
Ilika plc has announced the successful completion of its first commercial delivery of Stereax electrode to Cirtec Medical, marking a significant step in its commercial progress. This initial order, which represents Ilika's first revenue-generating shipment to Cirtec, will support the production of Stereax M300 batteries for active implantable medical devices. The electrodes are intended for validation and customer sampling across various applications, including implanted sensors, neurostimulators, and orthopaedic implants. This milestone demonstrates Ilika's capability to deliver commercial-grade electrodes from its UK facility to support Cirtec's manufacturing activities, with expectations to ramp up supply to meet demand.
Select text to share a quote on X · sign in to keep highlights & notes in your IKA notes
Ilika (AIM: IKA), the UK pioneer in solid state battery technology, announces it has successfully delivered its initial batch of commercial grade StereaxÒ electrode to Cirtec Medical (Cirtec) for Stereax M300 production.
In January 2026, Ilika that Cirtec had initiated the commercial electrode supply arrangement with Ilika to support product manufacturing. Ilika has now fulfilled the initial order, its first revenue-generating order from Cirtec.
The electrodes will be used in Stereax M300 batteries for validation and customer sampling across a wide range of active implantable medical device (AIMD) applications, including powering implanted sensors, neurostimulators, orthopaedic implants, orthodontic wearables and ophthalmology devices.
Shawn Martin, Vice President at Cirtec Medical, said: "Our close technical cooperation with Ilika has developed into an effective operational partnership, ensuring our customers will receive the highest quality product for integration into their devices. "
Graeme Purdy, CEO of Ilika, said: "This milestone demonstrates that Ilika's facility in the UK can deliver commercial-grade electrodes to support Cirtec's M300 manufacturing activities. We look forward to ramping our supply activities to meet customer demand."
About Cirtec Medical
Cirtec Medical is a global leader in design, development, and manufacturing of complex Class II and III medical devices, specializing inactive implant systems, interventional devices, precision components, and thin film and microelectronics. Since 1987, Cirtec Medical has built extensive in-house capabilities that enable the company to serve as a single-source partner and collaborate with customers to transform their technology into innovative medical devices across a wide array of therapies, including cardiology, neurology, orthopedics and other minimally invasive device applications. Cirtec Medical's deep expertise in precision component design and manufacturing supports every stage of the product lifecycle, ensuring uncompromising quality and performance. With 11 global facilities and a vertically integrated approach, Cirtec Medical aims to expedite time to market, reduce risk, and accelerate revenue generation for our partners. Learn more at CirtecMed.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.